A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial.
- Citation:
- Ann Oncol vol 28 (8) 1957-63
- Year:
- 2017
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Health Outcomes
- Pharmas:
- Grants:
- UG1 CA189823
- Corr. Author:
- Authors:
- A Jatoi P D Steen P J Atherton D F Moore K M Rowland N A Le-Lindqwister C S Adonizio A J Jaslowski J Sloan C Loprinzi
- Networks:
- CARLE, GEISINGER, HEARTLAND, KS055, LAPS-MN026, SANFORD, WINCORP
- Study
- NCCTG-N02C4
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- cachexia, creatine, nutrition, supportive care, weight loss